# Mikael Eriksson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mikael-eriksson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,296 |
| Field | BRCA gene mutations in cancer |
| h-index | 81 |
| i10-index | 290 |
| Last Known Institution | Lund University |
| OpenAlex ID | https://openalex.org/A5037999437 |
| ORCID iD | https://orcid.org/0000-0001-8135-4270 |
| Works | 585 |

## Researcher papers

Showing 12 of 16.

- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes](https://scholariq.org/papers/polygenic-risk-scores-for-prediction-of-breast-cancer-and-breast-cancer-subtypes/)
- [Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-genturis-clinical-practice/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort](https://scholariq.org/papers/survival-and-prognosis-with-osteosarcoma-outcomes-in-more-than-2000-patients-in/)
- [Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-for-diagnosis/)
- [Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer](https://scholariq.org/papers/genome-wide-association-analysis-of-more-than-120-000-individuals-identifies-15/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-genturis-clinical-practice/)
- [Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants](https://scholariq.org/papers/prediction-of-breast-cancer-risk-based-on-profiling-with-common-genetic-variants/)
- [Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial](https://scholariq.org/papers/comparison-of-mapie-versus-map-in-patients-with-a-poor-response-to-preoperative/)
- [Genetic insights into biological mechanisms governing human ovarian ageing](https://scholariq.org/papers/genetic-insights-into-biological-mechanisms-governing-human-ovarian-ageing/)
- [Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial](https://scholariq.org/papers/methotrexate-doxorubicin-and-cisplatin-map-plus-maintenance-pegylated-interferon/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Digital Radiography and Breast Imaging](https://scholariq.org/topics/digital-radiography-and-breast-imaging/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [AI in cancer detection](https://scholariq.org/topics/ai-in-cancer-detection/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)

## Researcher university

- [Lund University](https://scholariq.org/institutions/lund-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.